Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 May;42(5):1409-1421.
doi: 10.1007/s10067-022-06477-5. Epub 2023 Jan 24.

A pilot randomized controlled trial evaluating outdoor community walking for knee osteoarthritis: walk

Affiliations
Randomized Controlled Trial

A pilot randomized controlled trial evaluating outdoor community walking for knee osteoarthritis: walk

S J J Drummen et al. Clin Rheumatol. 2023 May.

Abstract

Objectives: To determine the feasibility of a randomized controlled trial (RCT) examining outdoor walking on knee osteoarthritis (KOA) clinical outcomes and magnetic resonance imaging (MRI) structural changes.

Method: This was a 24-week parallel two-arm pilot RCT in Tasmania, Australia. KOA participants were randomized to either a walking plus usual care group or a usual care control group. The walking group trained 3 days/week. The primary outcome was feasibility assessed by changes being required to the study design, recruitment, randomization, program adherence, safety, and retention. Exploratory outcomes were changes in symptoms, physical performance/activity, and MRI measures.

Results: Forty participants (mean age 66 years (SD 1.4) and 60% female) were randomized to walking (n = 24) or usual care (n = 16). Simple randomization resulted in a difference in numbers randomized to the two groups. During the study, class sizes were reduced from 10 to 8 participants to improve supervision, and exclusion criteria were added to facilitate program adherence. In the walking group, total program adherence was 70.0% and retention 70.8% at 24 weeks. The walking group had a higher number of mild adverse events and experienced clinically important improvements in symptoms (e.g., visual analogue scale (VAS) knee pain change in the walking group: - 38.7 mm [95% CI - 47.1 to - 30.3] versus usual care group: 4.3 mm [- 4.9 to 13.4]).

Conclusions: This study supports the feasibility of a full-scale RCT given acceptable adherence, retention, randomization, and safety, and recruitment challenges have been identified. Large symptomatic benefits support the clinical usefulness of a subsequent trial.

Trial registration number: 12618001097235. Key Points • This pilot study is the first to investigate the effects of an outdoor walking program on knee osteoarthritis clinical outcomes and MRI joint structure, and it indicates that a full-scale RCT is feasible. • The outdoor walking program (plus usual care) resulted in large improvements in self-reported knee osteoarthritis symptoms compared to usual care alone. • The study identified recruitment challenges, and the manuscript explores these in more details and provides recommendations for future studies.

Keywords: Aerobic; Exercise; Joint; MRI; Structure.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any conflicts of interest relevant to this study.

Figures

Fig. 1
Fig. 1
Flow diagram of participant recruitment and completion
Fig. 2
Fig. 2
VAS, WOMAC subscales, 30-s chair stand test, and changes in time spent in MVPA values in the walking and usual care group during 24 weeks of intervention (mean with 95% confidence interval). The data are estimates from linear mixed-effects models, adjusted for age, sex, and corresponding baseline values. Abbreviations: MVPA, moderate to vigorous physical activity; VAS, visual analogue scale; WOMAC, Western Ontario and McMaster University Index; W, walking; UC, usual care

Similar articles

Cited by

References

    1. Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325:568–578. doi: 10.1001/jama.2020.22171. - DOI - PMC - PubMed
    1. Deveza LA, Loeser RF. Is osteoarthritis one disease or a collection of many? Rheumatology. 2018;57:iv34–iv42. doi: 10.1093/rheumatology/kex417. - DOI - PMC - PubMed
    1. Bennell KL, Bayram C, Harrison C, Brand C, Buchbinder R, Haas R, Hinman RS. Trends in management of hip and knee osteoarthritis in general practice in Australia over an 11-year window: a nationwide cross-sectional survey. The Lancet Regional Health-Western Pacific. 2021;12:100187. doi: 10.1016/j.lanwpc.2021.100187. - DOI - PMC - PubMed
    1. Bernetti A, Agostini F, Alviti F, Giordan N, Martella F, Santilli V, Paoloni M, Mangone M. New viscoelastic hydrogel hymovis MO. RE. Single Intra-articular injection for the treatment of knee osteoarthritis in sportsmen: safety and efficacy study results. Front Pharmacol. 2021;12:673988. doi: 10.3389/fphar.2021.673988. - DOI - PMC - PubMed
    1. Bernetti A, Mangone M, Paolucci T, Santilli V, Verna S, Agostini F, Paoloni M. Evaluation of the efficacy of intra-articular injective treatment with reticular hyaluronic acid (Mo. Re. Technology) in amateur athletes with over-use gonarthrosis. Med Sport. 2020;73:127–139. doi: 10.23736/S0025-7826.20.03648-0. - DOI

Publication types

LinkOut - more resources